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Abstract
Background: Site-directed mutagenesis is an efficient method to alter the structure and function
of genes. Here we report a rapid and efficient megaprimer-based polymerase chain reaction (PCR)
mutagenesis strategy that by-passes any intermediate purification of DNA between two rounds of
PCR.
Results: The strategy relies on the use of a limiting concentration of one of the flanking primers
(reverse or forward) along with the normal concentration of mutagenic primer, plus a prolonged
final extension cycle in the first PCR amplification step. This first round of PCR generates a
megaprimer that is used subsequently in the second round of PCR, along with the second flanking
primer, but without the intermediate purification of the megaprimer. The strategy has been used
successfully with four different plasmids to generate various mutants.
Conclusion: This strategy provides a very rapid, inexpensive and efficient approach to perform
site-directed mutagenesis. The strategy provides an alternative to conventional megaprimer based
site-directed mutagenesis, which is based on an intermediate gel purification step. The strategy
gives a high frequency of mutagenesis.
Background
Oligonucleotide-directed mutagenesis is one of the most
popular methods to introduce site-specific alterations into
a DNA sequence. In past few years, various protocols have
been established for site-directed mutagenesis, which
facilitate the analysis of gene expression and function.
Currently, various PCR-based mutagenesis strategies are
available but among them 'megaprimer'-based PCR has
been used widely because of its simplicity and low cost
[1].
Kammann et al. [2] originally developed the megaprimer-
based mutagenesis strategy. Later, various changes have
been suggested [3-7] to the original strategy. These meg-
aprimer-based mutagenesis strategies are easy to use and
they are very cost effective. The strategies require two
rounds of PCR amplification using two flanking primers
and one internal mutagenic primer. In the first round of
PCR, one of the flanking primers and the internal muta-
genic primer (having desired base substitutions) are used
to generate a megaprimer. The megaprimer is purified by
gel electrophoresis and extraction before being used along
with the other flanking primer in the second round of
PCR to generate the complete DNA sequence with the
desired mutation.
Most of the reported megaprimer mutagenesis strategies
rely on the intermediate purification of megaprimer after
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the first round of PCR amplification to remove the unused
primers. This requires the use of cumbersome and time-
consuming gel extraction steps. Three megaprimer based
site-directed mutagenesis strategies are available at
present that circumvent the gel purification step. The first
one uses various restriction enzymes to cleave the first and
second PCR templates and enzymatic removal of remain-
ing primers from the first PCR reaction [8]. Since this strat-
egy is based on the use of DNA-modifying enzymes at
various steps, it is complicated and expensive to use. In
the second strategy the melting temperature (Tm) of the
forward and reverse flanking primers play a critical role
[9]. A megaprimer is generated using a low Tm flanking
primer and a low annealing temperature. The second PCR
is carried out in the same tube and uses a high Tm flanking
primer that prevents priming by the low Tm primer from
the first PCR reaction, thereby obviating the need to gel-
purify the megaprimer after the first PCR. However, the
strategy is limited by the need to design primers in which
one has a Tm that is substantially higher than the other;
moreover, the average mutant frequency is approximately
80%. The third single tube strategy utilizes the three prim-
ers, including mutagenic primer, in three steps of PCR
amplification to generate the mutant using different com-
binations of primers [10]. The average mutagenesis fre-
quency obtained with this strategy is about 50%. The
complex, three-step PCR protocol, along with the lower
average mutagenesis frequency, makes this strategy lim-
ited in use.
In this paper we describe an efficient and inexpensive sin-
gle-tube two-step megaprimer-based PCR mutagenesis
strategy (Fig. 1) that by-passes the cumbersome and time-
consuming gel purification step, does not require addi-
tional expensive DNA-modifying enzyme treatments, is
not restrictive in primer design, and has a high mutational
efficiency. This strategy has been applied successfully to
generate mutants of four different proteins; namely, ace-
tohydroxyacid synthase (AHAS) from Arabidopsis thaliana,
the catalytic and regulatory subunits of Saccharomyces cer-
evisiae  AHAS, and Escherichia coli ketol-acid reductoi-
somerase (KARI). To illustrate this strategy, quantitative
results obtained with KARI are presented in this paper,
together with semi-quantitative analyses for the remain-
ing three constructs. The average mutagenesis frequency
obtained with this new strategy approaches 100% under
optimal conditions.
Results
We tested our new strategy by making a KARI mutant. The
first PCR contained 0.05, 0.1 or 1.0 pmole of the first
flanking primer (T7 terminator). The second PCR prod-
ucts (1837 bp) (Fig. 2, lanes 1–3) were cloned into the
pPROEX™HTb vector, and used to transform E. coli
CU505 cells. To calculate the mutagenesis frequency of
the new strategy, several colonies from each experiment
were picked and sequenced (Fig. 2). A mutant frequency
of 100% was observed when 0.05 pmole of the first flank-
ing primer was used in the first PCR, but the efficiency
decreased drastically (36%) when a normal amount of
Outline of the new strategy described in this paper. Figure 1
Outline of the new strategy described in this paper. 
The first PCR (5 cycles) contains a limiting concentration of 
the first flanking primer and is followed by a prolonged 
extension step. The second flanking primer is then added and 
the entire mutated template is amplified by PCR (25 cycles). 
The second PCR product is digested with appropriate 
restriction endonucleases to give desired mutated fragment, 
which then can be ligated to the expression vector.BMC Biotechnology 2004, 4 http://www.biomedcentral.com/1472-6750/4/2
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primer (1.0 pmole) was used. As we had anticipated, there
is a lower percentage of mutant clones as the amount of
the first flanking primer increases, presumably because
residual first flanking primer is competing with the meg-
aprimer in the second PCR, thereby amplifying the wild-
type sequence. A limited amount of the first flanking
primer is a key step in our new strategy.
The advantage of prolonged final extension steps was
demonstrated in an experiment where the amount of the
Agarose gel representing the results of megaprimer based PCR mutagenesis products and effect of limiting first flanking primer  concentration on mutation frequency. Figure 2
Agarose gel representing the results of megaprimer based PCR mutagenesis products and effect of limiting 
first flanking primer concentration on mutation frequency. Lanes 1, 2 and 3 are results obtained using 0.05, 0.1 and 1.0 
pmole of the first flanking primer (T7 terminator) in the first PCR reaction. Lane M contains 1 µg of GeneRuler™ DNA ladder 
mix. The second PCR (1837 bp) product was purified from the gel. It was subjected to double restriction digestion using 
BamHI &HindIII. The resulting fragment (1482 bp) was cloned into the expression vector. The clones were sequenced to calcu-
late the mutagenesis frequency.BMC Biotechnology 2004, 4 http://www.biomedcentral.com/1472-6750/4/2
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first flanking primer was lowered (0.05 pmole) but the
prolonged final extension step was omitted. Under these
conditions, almost no second PCR product was obtained
(Fig. 3, lane C).
Our new strategy was applied to three other templates,
using diagnostic restriction digestion to estimate the
mutation efficiency without performing sequencing. In
the case of the N346H mutation in the regulatory subunit
of AHAS from A. thaliana [11], the second PCR product
obtained using 0.05, 0.1 and 1.0 pmole of the first flank-
ing primer, when digested with KpnI, showed different rel-
ative band intensity patterns when run on 1% agarose gel.
The second PCR product obtained using 0.05 pmole of
the first flanking primer showed only the bands corre-
sponding to the anticipated mutant with no band of undi-
gested (wild-type) product. In the 0.1 and 1.0 pmole
experiments, a mixture of both wild-type and mutant was
observed. The intensity of bands corresponding to mutant
was very strong as compared to the wild-type for the 0.1
pmole experiment, while for the 1.0 pmole experiment an
opposite banding pattern was observed. These results are
consistent with our quantitative measurements on the
KARI mutant. The strategy was also used to construct
mutants of the regulatory subunit (D224A; Pham et al.,
unpublished) and catalytic subunit (M354V; [12]) of S.
cerevisiae AHAS. The D224A mutagenic primer removes an
EcoRV recognition site, while the M354V primer intro-
duces a restriction site for ApaLI. Both mutations were
tested using the same three different concentrations of
first flanking primers. The results obtained from both of
these mutants were in agreement with those obtained
with the N346H mutant of A. thaliana AHAS.
Discussion
The main reason for using a gel purification step after the
first PCR in conventional megaprimer mutagenesis is to
remove excess flanking primer. Without this step, the sec-
ond PCR would contain both of the flanking primers and
substantial amounts of wild-type product would be
Agarose gel representing the results of the importance of prolonged extension cycle. Figure 3
Agarose gel representing the results of the importance of prolonged extension cycle. Lane M contains 1 µg of 
GeneRuler™ DNA ladder mix and lane C shows the results of an experiment using 0.05 pmole of the first flanking primer but 
conducted without prolonged extension cycles.BMC Biotechnology 2004, 4 http://www.biomedcentral.com/1472-6750/4/2
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obtained. One of the novel features of our strategy (Fig. 1)
is that the amount of the first flanking primer is limited,
so that it is substantially depleted during the first PCR.
This, in turn, leads to the second novel feature of our strat-
egy, a prolonged extension step at the end of the first PCR.
Because the amount of the first flanking primer is limited,
a relatively small number of PCR cycles are sufficient to
reach an end point. However, the small number of cycles
constrains one of the essential features of PCR: full-length
products accumulate exponentially while incomplete
products accumulate arithmetically. Therefore, after just a
few PCR cycles, full-length products will not overwhelm
the partial products. We overcame this problem with a
final and prolonged extension step, so that all of the par-
tial products are converted to full-length products.
The second flanking primer is added after the first PCR
step; no other additions or manipulations are necessary,
in contrast with other single tube PCR strategies that have
been described previously [8-10]. Most of the megaprimer
strategies are limited in the length of the megaprimer to
about 300 bp [13]. The length of megaprimer does not
limit our strategy, which can be used for in excess of 1 kbp
long megaprimers (Table 1). This strategy is also useful in
terms of PCR set up; it is only necessary to program the
software to pause between the two PCR stages, while the
second flanking primer is added.
Conclusions
The results of sequencing experiments in the case of the
KARI mutant, and diagnostic restriction digestion in the
case of other three constructs, show the versatility of our
strategy. Although there are currently three single PCR
tube strategies available, ours is simpler and yields muta-
genesis frequencies approaching 100%. We suggest that it
could be applied to most constructs making it a simple
but universal strategy for site-directed mutagenesis.
Methods
All PCR experiments were performed on a Perkin-Elmer
480 thermal cycler. Restriction enzymes, DNA ligase and
DNA polymerase were obtained from New England
Biolabs. Deoxyribonucleotide triphosphates (dNTPs)
were purchased from Promega and the primers were
obtained from Sigma-Aldrich Pty. Ltd. The mutagenic
primers (Table 1) differed from the wild-type sequence by
containing substitutions to change one amino acid resi-
due. Mini preparation of plasmid DNA was performed
using the Promega Plasmid Preparation Kit.
Our new strategy has been applied to four different pro-
teins but for illustration the strategy to construct a mutant
of E. coli KARI will be described in detail. Isolating clones
followed by DNA sequencing was used to assess the suc-
cess of the strategy. For the other three enzyme constructs,
the designed mutagenic primers contained altered restric-
tion enzyme recognition sites to permit facile screening
for the mutant (Table 1). In one case; the target codon
change was chosen so as to create a restriction enzyme rec-
ognition site, while in a second case an existing site was
removed. A third mutagenic primer contained a second
substitution that is silent with respect to the protein
sequence but which introduced a restriction enzyme rec-
ognition site. The resulting mutants were screened using
diagnostic restriction digestion.
The ilvC gene (1482 bp) encodes KARI and the gene prod-
uct is a single polypeptide with a deduced molecular
weight of 54 kDa [14]. We have described previously the
cloning of the gene into the pET30a(+) vector [15]. The
pET-C (6879 bp) plasmid was used as the template.
This new strategy consists of two rounds of PCR amplifi-
cation. In the first round, the reaction was carried out in
total volume of 50 µL and contained 2 U of Vent polymer-
ase, 1X ThermoPol PCR buffer (10 mM KCl, 10 mM
(NH4)2SO4, 20 mM Tris-HCl (pH 8.8 at 25°C), 2 mM
MgSO4 and 0.1% Triton® X-100), 50–100 ng of pET-C
DNA, 0.2 mM dNTP, 1.0 pmole of internal mutagenic for-
ward primer (Table 1) and 0.05 pmole of the reverse
flanking primer (T7 terminator, GGTTATGCTAGTTATT-
GCTCAGCGGTGGC). The PCR was carried out under the
following conditions: denaturation, 95°C for 1 minute;
annealing, 50°C for 30 seconds; and extension, 72°C for
Table 1: Mutations, primers and restriction enzyme recognition site added or removed.
Template Mutation Mutagenic primer sequence Megaprimer (bp) Enzyme
E. coli KARI E213D 5'-GTCCTTCGTTGCGGAcAAATCTGACCTG-3' (F) 968 Nil
A. thaliana AHAS Regulatory subunit N346H 5'-CGAAGGGGgTACcaTATCCAGAGC-3' (F) 705 KpnI
S. cerevisiae AHAS Regulatory subunit D224A 5'-GGTCAAGTTGGTGATAgCGTT-3' (R) 805 EcoRV
S. cerevisiae AHAS Catalytic subunit M354V 5'-CAACCGTGCAcACCAAGCATATCC-3' (R) 1127 ApaL1
In the primer sequences shown, bases that differ from the wild-type are shown in lowercase and the altered codon is underlined. Boxes enclose 
introduced restriction enzyme recognition sites, while strikethrough shows a restriction enzyme recognition site that is removed. The designations 
(F) and (R) indicate forward and reverse primers, respectively.Publish with BioMed Central    and   every 
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2 minutes. This cycle was repeated 5 times and followed
by an additional extension step at 72°C for 35 minutes. In
the second round of PCR, the forward flanking primer (T7
promoter, CGCGAAATTAATACGACTCACTATAGGGG)
was added into the same tube. After an initial denatura-
tion of 96°C for 1 minute, 25 PCR cycles were used as fol-
lows: denaturation, 96°C for 1 minute; annealing, 55°C
for 1 minute; and extension, 72°C for 2 minutes. These
cycles were followed by an additional extension step at
72°C for 10 minutes. The second PCR product (1837 bp)
having desired mutation was purified and digested with
BamHI and HindIII to give a mutated ilvC gene fragment
(1482 bp). The resulting fragment was purified and
cloned into the expression vector pPROEX™HTb (4779
bp) (Gibco BRL) after digesting vector with BamHI and
HindIII. The resulting mutant plasmid (6192 bp) was
used to transform E. coli strain CU505 (Purdue University,
Indiana, USA) competent cells and 10% of the trans-
formed culture was cultured on Luria-Bertani agar plates
supplemented with 10 µg/ml ampicillin. The plasmid iso-
lated from selected colonies was sequenced using
BigDye™ Terminator chemistry at the Australian Genome
Research Facility (Brisbane, Queensland, Australia).
List of abbreviations
PCR: polymerase chain reaction; bp: base pairs; kbp: kilo
base pairs; Tm: melting temperature.
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